You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion Biopharma supports the launch of "Nature Italy"

The Company reaffirms and strengthens its commitment to research and innovation

read more 

CORPORATE

Kedrion announces the appointment of a new CEO

Val Romberg from the USA, one of the most esteemed managers in the industry

read more 

EVENTS

Kedrion supports the 2020 European Hemophilia Consortium Conference

The company renews its commitment alongside the EHC, which continues to support the PARTNERS project

read more 
  1. FEATURED STORIES - 04-01-2020

    In memory of Fabrizio Fabbrizzi

    Written by: Albert Farrugia

    read more 
  2. EVENTS - 25-11-2019

    Kedrion alongside IPOPI at the IPIC Congress in Madrid

    The importance of early diagnosis and the most recent innovations in the treatment of PID patients were the focus

    read more 
  3. EVENTS - 15-11-2019

    Kedrion keeps Hemophilia therapy debate flowing in Latin America

    A recent CLAHT Congress symposium restates current and future role of replacement therapy

    read more 
  4. CORPORATE - 16-10-2019

    FSI SGR enters Kedrion share capital

    The company continues with its growth and development strategy

    read more 

Pages

For more information please contact: pressoffice@kedrion.com